Zacks Investment Research upgraded shares of Immuron Limited – American Depositary Shares (NASDAQ:IMRN) from a hold rating to a buy rating in a research note published on Tuesday morning. They currently have $14.00 target price on the stock.
According to Zacks, “Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia. “
Separately, HC Wainwright restated a buy rating and set a $20.00 price objective on shares of Immuron Limited – American Depositary Shares in a report on Friday, March 9th.
Shares of Immuron Limited – American Depositary Shares (NASDAQ IMRN) opened at $11.10 on Tuesday. Immuron Limited – American Depositary Shares has a 1-year low of $4.47 and a 1-year high of $16.70.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Stock Observer and is the property of of Stock Observer. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.thestockobserver.com/2018/03/21/immuron-limited-american-depositary-shares-imrn-upgraded-to-buy-by-zacks-investment-research.html.
Immuron Limited – American Depositary Shares Company Profile
Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle.
Receive News & Ratings for Immuron Limited - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron Limited - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.